Author Archives: Kenneth
Trusting drugs manufactured in China or India?
70% of Americans are “not confident” that prescription drugs made in China are safe and free from contamination, and 54% have the same reservations about medicines produced in India, according to a new survey.
Posted in General
Leave a comment
Sanofi ready to bid for Genzyme
Let the bidding begin. Sanofi-Aventis has set its eyes on Genzyme as it can us Genzyme’s storehouse of biotech knowledge. There appears to be a basic agreement that the pharma company will get started at $68 to$70 a share while … Continue reading
Posted in General
Leave a comment
Medical Innovation
According to the study Gone Tomorrow? A Call to Promote Medical Innovation, Create Jobs, and Find Cures in America, the US is facing serious challenges when it comes to medical innovation. It will become difficult for America to maintain its … Continue reading
Posted in General
Leave a comment
Roche has obtained a licence for a biomarker from Qiagen
Roche has linked up with Qiagen from the Netherlands to develop tests for a key cancer biomarker. The large company from Switzerland has obtained a worldwide co-exclusive licence for the biomarker PI3K (phosphoinositide 3-kinase) from Qiagen to develop diagnostic assays.
Posted in Deals & Acquisitions
Leave a comment
Sanofi-Aventis buys TargeGen for a total of $560 million
Sanofi-Aventis has this morning revealed it has agreed to purchase privately-held TargeGen Inc. to add treatments for certain forms of leukemia and blood disorders. Sanofi will pay $75 million as an upfront-payment to TargeGen, which is developing small molecule kinase inhibitors … Continue reading
Posted in Deals & Acquisitions
1 Comment